SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?


To: nokomis who wrote (79400)1/18/2000 6:09:00 PM
From: kha vu  Read Replies (2) | Respond to of 120523
 
BIOTECH review especially about SEPR
<<<Sepracor (NASDAQ:SEPR - news) . All of these, Kam notes, will provide better research for new drugs, much as the study of the genome will provide better targets for those drugs. Kam says Sepracor “is reaching the eighth year of a 10-year development cycle, and they are going to own the antihistamine market.

messages.yahoo.com
>>>>>>>>>